BELLUS Health Inc - Company Profile

Powered by

All the sales intelligence you need on BELLUS Health Inc in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how BELLUS Health Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with BELLUS Health Inc.

Back to companies

BELLUS Health Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

BELLUS Health Inc (BELLUS Health) is a clinical-stage biopharmaceutical company that focuses on developing novel therapeutics for treating patients with chronic cough and hypersensitization-related disorders. The company’s lead product, BLU-593 (formerly NEO5937) is a potent, orally bio-available, highly selective small-molecule antagonist of the P2X3 receptor which is being developed for treating refractory chronic cough, and chronic pruritus associated with atopic dermatitis. The company has license agreement and collaborations with NEOMED institute for the development and commercialization of BLU-593. The company operates in Canada and the US through its subsidiaries. BELLUS Health is headquartered in Laval, Quebec, Canada.

 Gain a 360-degree view of BELLUS Health Inc and make more informed decisions for your business Gain a 360-degree view of BELLUS Health Inc and make more informed decisions for your business Learn more
Headquarters Canada
Address 275 Armand-Frappier Blvd, Laval, Quebec, H7V4A7
Website bellushealth.com
Telephone 1 450 6804500
No of Employees 74
Industry Pharmaceuticals and Healthcare
Revenue (2022) $16,000
   
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

BELLUS Health Inc premium industry data and analytics

40+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for BELLUS Health Inc’s relevant decision makers and contact details.

20+

Catalyst Calendar

Proactively evaluate BELLUS Health Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

20+

Clinical Trials

Determine BELLUS Health Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

13+

Pipeline Drugs

Identify which of BELLUS Health Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

5

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

Image for loader
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into BELLUS Health Inc key executives to enhance your sales strategy Gain insight into BELLUS Health Inc key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?